Vilija G. Jokubaitis

Level 6, 99 Commercial Rd
Melbourne, VIC 3004, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 123 publications

Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.

Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 18, 2026

Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.

Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 03, 2026

Association between pregnancy timing and disability outcomes in women with mild relapse-onset multiple sclerosis.

Association between pregnancy timing and disability outcomes in women with mild relapse-onset multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 29, 2026

Genetic Risk in Multiple Sclerosis: Susceptibility, Modifiers and Unresolved Questions.

Genetic Risk in Multiple Sclerosis: Susceptibility, Modifiers and Unresolved Questions.

Journal: Neurology and therapy

Published: June 02, 2026

Modern diagnosis and treatment of multiple sclerosis: advances, challenges, and future directions.

Modern diagnosis and treatment of multiple sclerosis: advances, challenges, and future directions.

Journal: Autoimmunity reviews

Published: May 11, 2026

Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: April 28, 2026

Menopause is a physiological progression event for women with multiple sclerosis: No.

Menopause is a physiological progression event for women with multiple sclerosis: No.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: April 01, 2026

Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder.

Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder.

Journal: Neurology

Published: March 05, 2026

Inter-attack serum GFAP and NfL remain stable over 9 years in AQP4 IgG NMOSD.

Inter-attack serum GFAP and NfL remain stable over 9 years in AQP4 IgG NMOSD.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: January 21, 2026

Violence and multiple sclerosis: Towards an evidence-informed call to action in neurology.

Violence and multiple sclerosis: Towards an evidence-informed call to action in neurology.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: January 13, 2026

Violence and multiple sclerosis: Towards an evidence-informed call to action in neurology.

Violence and multiple sclerosis: Towards an evidence-informed call to action in neurology.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: January 13, 2026

Study protocol for a mixed methods convergent investigation of family domestic and sexual violence in multiple sclerosis and broader neurology in Australia.

Study protocol for a mixed methods convergent investigation of family domestic and sexual violence in multiple sclerosis and broader neurology in Australia.

Journal: PloS one

Published: December 11, 2025

Showing 1-12 of 123

Last Updated: 09/26/2026